CSPC Pharmaceutical Group Limited (FRA:CVG)

Market Cap	11.33B -8.8%
Revenue (ttm)	4.04B +20.5%
Net Income	957.21M +92.7%
EPS	0.08 +94.6%
Shares Out	n/a
PE Ratio	11.84
Forward PE	11.46
Dividend	0.04 (3.75%)
Ex-Dividend Date	Oct 20, 2026

Volume	n/a
Open	0.9800
Previous Close	0.9635
Day's Range	0.9800 - 0.9800
52-Week Range	0.7265 - 1.1290
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 17, 2026

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 18,626
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVG

Financial Performance

In 2025, CSPC Pharmaceutical Group's revenue was 26.01 billion, a decrease of -10.35% compared to the previous year's 29.01 billion. Earnings were 3.88 billion, a decrease of -10.30%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error